Ophthalmology Drugs Market is Forecast to Grow at $26 billion in 2022 Ophthalmology Drugs Market is Forecast to 2022

Ophthalmology Drugs Market is Forecast to
Grow at $26 billion in 2022: Radiant
Insights, Inc
“Global revenues for the ophthalmology market are
forecast to grow at a compound annual growth rate
of 9.48%, from $13.7 billion in 2015 to $26 billion in
2022.”
Summary
Ophthalmology is a therapy area that deals with the diagnosis, treatment and prevention of
diseases associated with the eyes and visual system. Most eye disorders occur over a long period
of time, and are initially asymptomatic or cause only a slight decrease in vision. However, over
time this becomes quite marked. Ophthalmologic disorders cannot currently be cured, and
treatment is aimed at managing the disease indication in order to reduce the severity of symptoms
and slow progression.
Angiogenesis inhibitors are the most effective and most common therapies used in
ophthalmology; this class of compounds has been the most commercially successful in the past
decade, with products such as Eylea and Lucentis generating strong annual revenues. Although
there are many generics available across the majority of ophthalmology disorders, there are a
number of premium products that attract substantial revenues –
Access This Full Report @ http://www.radiantinsights.com/research/global-
ophthalmology-drugs-market-to-2022
Follow Us: